EP4192882
TREATMENT OF LUPUS NEPHRITIS WITH ANTI-TYPE I INF RECEPTOR ANTIBODY ANIFROLUMAB
:
EP einkaleyfi: Þýðing ekki lögð inn:
22.4.2022:
19.2.2025:
22724712.9
:
21.4.2042
:
TREATMENT OF LUPUS NEPHRITIS WITH ANTI-TYPE I INF RECEPTOR ANTIBODY ANIFROLUMAB
22.4.2022
19.2.2025
:
Astrazeneca AB:
151 85 Södertälje, SE
:
LINDHOLM, Catharina:
151 85 Södertälje, SE
:
CHIA, Yen Lin:
Wilmington, Delaware 19850-5437, US
:
TUMMALA, Rajendra:
Wilmington, Delaware 19850-5437, US
:
ROSKOS, Lorin:
Gaithersburg, Maryland 20878, US
:
ALMQUIST, Joachim:
151 85 Södertälje, SE
:
ROUSE, Tomas:
151 85 Södertälje, SE
:
TRASIEVA, Teodora:
151 85 Södertälje, SE
:
WHITE, Wendy:
Gaithersburg, Maryland 20878, US
:
SINIBALDI, Dominic:
Gaithersburg, Maryland 20878, US
:
RAMASWAMY, Madhu:
Gaithersburg, Maryland 20878, US
:
NEWCOMBE, Paul:
Cambridge Cambridgeshire CB2 0AA, GB
:
202163178745 P:
23.4.2021:
US
:
202163221986 P:
15.7.2021:
US
:
202163270091 P:
21.10.2021:
US
:
EP2022060670:
22.4.2022
:
C07K 16/28, A61P 29/00, G01N 33/53, A61M 5/00